window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-EE4YC2THRT');

News

July 26, 2023

New resources: A new framework for methadone carries

We have recently produced a set of documents outlining a new framework for making decisions about ta

READ MORE
September 22, 2022

Information for people on methadone and health care providers about new generic methadone products

Two new generic methadone products have been added to the Ontario provincial formulary. As of Septem

READ MORE
May 30, 2022

Take-home Naloxone Program in EDs and Hospitals

These materials are intended for EDs and hospitals who want to set up their own take-home naloxone p

READ MORE
April 19, 2022

Take-Home Naloxone Bulletin

The Ontario Naloxone Program (ONP) and META:PHI have prepared a bulletin on the importance of making

READ MORE
February 10, 2022

Looking for META:PHI community consultants

In order to improve the quality and credibility of our materials, META:PHI would like to assemble a

READ MORE

Latest resources

Recommendations
Recommendations on the Management of Selected Alcohol-Related Presentations in the Emergency Department

These recommendations for the management of alcohol-related emergency department (ED) presentations were developed by a group of people with professional and/or experiential expertise of alcohol use. Part of Toolkit for Alcohol-Related Presentations to the Emergency Department Version date: 15 December 2023

PDF, 161kB
Featured
Recommendations For Use of Slow-Release Oral Morphine as Opioid Agonist Therapy

Bringing together published evidence and both clinical and experiential expertise, these recommendations are intended to guide prescribers in the use of slow-release oral morphine (SROM, brand name Kadian) as opioid agonist therapy (OAT). Authors: Karan Cheema, Meldon Kahan, Jason Rodgers, Ashley Smoke, Suzanne Turner, Jennifer Wyman, Maria Zhang Reviewers: Lisa Bromley, Katie Dunham, Caryn Green, Janelle Hannon, Christina Henry, Cassandra Huck, Laura Jones, Kate Lazier, Andrew McLeod, Charlotte Munro, Patrick Nowak, Lori Regenstreif, Michael Roach, Elizabeth Shouldice, Anita Srivastava Design: Brent Logan Version date: 01 November 2023

PDF, 317kB
Featured
Slow-release oral morphine as opioid agonist therapy: Plain language summary

A plain-language summary of the document “Recommendations for the use of slow-release oral morphine as opioid agonist therapy”, intended for patients interested in learning about slow-release oral morphine (SROM, brand name Kadian) as opioid agonist therapy (OAT). Authors: Karan Cheema, Meldon Kahan, Jason Rodgers, Ashley Smoke, Suzanne Turner, Jennifer Wyman, Maria Zhang Reviewers: Lisa Bromley, Katie Dunham, Caryn Green, Janelle Hannon, Christina Henry, Cassandra Huck, Laura Jones, Kate Lazier, Andrew McLeod, Charlotte Munro, Patrick Nowak, Lori Regenstreif, Michael Roach, Elizabeth Shouldice, Anita Srivastava Design: Brent Logan Version date: 01 November 2023

PDF, 96kB
Featured
Opioid Agonist Therapy Decision Aid Tool

A tool for patients to use with their health care providers to help them decide what opioid agonist therapy (OAT) option would be best for them: sublingual buprenorphine (Suboxone), depot buprenorphine (Sublocade), methadone, or slow-release oral morphine (Kadian). Authors: Karan Cheema, Meldon Kahan, Jason Rodgers, Ashley Smoke, Suzanne Turner, Jennifer Wyman, Maria Zhang Reviewers: Lisa Bromley, Katie Dunham, Caryn Green, Janelle Hannon, Christina Henry, Cassandra Huck, Laura Jones, Kate Lazier, Andrew McLeod, Charlotte Munro, Patrick Nowak, Lori Regenstreif, Michael Roach, Elizabeth Shouldice, Anita Srivastava Design: Brent Logan Version date: 01 November 2023

PDF, 74kB